Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex early phase 1/2 data shows promise for type 1 diabetes stem cell therapy
Seeking Alpha
Mon, 10/18/21 - 11:53 am
Vertex Pharmaceuticals
VX-880
type 1 diabetes
stem cells
cell therapy
clinical trials
Atlas backs a longtime Vertex employee’s quest to bring CF success to numerous other diseases
Endpoints
Thu, 10/14/21 - 11:06 am
Vertex Pharmaceuticals
Atlas
cystic fibrosis
R&D
Vertex Wants To Prove It's Not Another Biotech One-Hit Wonder
Yahoo/Bloomberg
Wed, 10/6/21 - 10:59 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
'This is the time to double down': Top Vertex executives defend research plan as pressure builds
BioPharma Dive
Wed, 09/22/21 - 11:15 am
Vertex Pharmaceuticals
clinical trials
R&D
AAT
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Motley Fool
Mon, 09/6/21 - 09:03 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Arbor Biotechnologies
Vertex, looking to broaden its gene editing abilities, asks a young biotech for help
BioPharma Dive
Tue, 08/24/21 - 11:02 pm
Vertex Pharmaceuticals
gene editing
Arbor Pharmaceuticals
Vertex Hopes to Channel CF Drug Successes into Other Therapies in the Pipeline
BioSpace
Fri, 07/30/21 - 11:22 am
Vertex Pharmaceuticals
earnings
cystic fibrosis
3 Biotechs That Could Make Big Acquisitions This Year
Motley Fool
Thu, 07/22/21 - 11:10 am
M&A
AbbVie
Vertex Pharmaceuticals
Gilead Sciences
Despite Hitting Mid-Stage Trial Endpoint Goal, Vertex Strikes Out Rare Lung Disease Candidate; Stock Tumbles
Yahoo/Benzinga
Fri, 06/11/21 - 10:45 am
Vertex Pharmaceuticals
VX-864
alpha-1 antitrypsin deficiency
clinical trials
Vertex stops work on second rare disease drug after study results disappoint
BioPharma Dive
Thu, 06/10/21 - 11:36 pm
Vertex Pharmaceuticals
VX-864
cystic fibrosis
Vertex picks a horse in race for opioid painkiller replacement
Fierce Biotech
Mon, 04/26/21 - 11:07 am
Vertex Pharmaceuticals
VX-548
clinical trials
painkillers
non-opioid pain treatments
Vertex adds a new gene editing partner, paying Obsidian $75M for controllable CRISPR system
Endpoints
Thu, 04/22/21 - 10:54 am
Vertex Pharmaceuticals
gene editing
CAR-T
Obsidian
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Tue, 04/20/21 - 11:16 pm
Biogen
aducanumab
FDA
Vertex Pharmaceuticals
Sarepta Therapeutics
JNJ
AstraZeneca
vaccines
COVID-19
Vertex puts a blockbuster valuation on its CRISPR deal
EP Vantage
Tue, 04/20/21 - 11:05 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
CTX001
M&A
Vertex’s second try at a rare lung disorder
EP Vantage
Thu, 04/15/21 - 10:07 am
Vertex Pharmaceuticals
VX-814
alpha-1 antitrypsin
Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient
Endpoints
Tue, 02/2/21 - 10:27 am
Vertex Pharmaceuticals
M&A
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
Endpoints
Fri, 01/29/21 - 09:54 am
Vertex Pharmaceuticals
Semma Therapeutics
M&A
gene therapy
VX-880
type 1 diabetes
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Yahoo/Zacks.com
Wed, 01/27/21 - 08:03 pm
Vertex Pharmaceuticals
cystic fibrosis
priority revies
FDA
Trikafta
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
BioPharma Dive
Mon, 01/11/21 - 07:06 pm
JPMHC 2021
Biogen
Vertex Pharmaceuticals
Sarepta Therapeutics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »